RegMed Forum 2027: From pluripotent stem cells (PSCs) to Next-Generation Gene and Cell Therapies

The RegMed Forum 2027 highlights the latest advances in pluripotent stem cell-based gene and cell therapies and addresses key challenges in their clinical translation and fosters the collaboration between academia, industry, start-ups, and clinicians to accelerate the development and implementation of next-generation regenerative therapies.

Human Pluripotent stem cells (hPSCs) have emerged as a transformative platform for regenerative therapies, enabling patient-specific disease modeling, drug discovery, and the development of advanced gene and cell-based treatments. Rapid scientific and technological progress is driving innovative approaches for the generation, differentiation, and clinical translation of PSC-derived products.

The RegMed Forum 2027 will showcase cutting-edge developments in hPSC-based regenerative therapies, with a focus on novel gene- and cell-based therapeutic strategies, cell differentiation and functional maturation, scalable GMP-compliant manufacturing, and advanced quality control. Attention will be given to emerging concepts aimed at improving the safety, efficacy, quality assurance, and accessibility of next-generation therapies within the framework of current regulatory requirements.

By bringing together leading experts from academia, innovative start-ups, and industry from Germany and beyond, the RegMed Forum aims to foster interdisciplinarystart exchange on the challenges of clinically translating advanced therapeutic approaches, including advanced therapy medicinal products (ATMPs), advanced medical devices, and combined products. The Forum seeks to encourage strategic partnerships and accelerate the translation of scientific discoveries into clinical and commercial applications. The sessions will provide a comprehensive overview of current challenges and emerging opportunities in the rapidly evolving hPSC landscape of gene and cell-based therapies.

An accompanying industry exhibition will provide a dedicated platform for companies and technology providers to showcase novel tools, services, and therapeutic approaches, facilitating direct interaction among researchers, clinicians, entrepreneurs, and industry partners.

Our target audience includes representatives from academia, start-ups, and industry, such as translational scientists, clinicians involved in clinical trials, manufacturers, trial sponsors, and providers of innovative gene- and cell-based therapies. In conclusion, the scientific program and industry exhibition will foster networking, interdisciplinary exchange, and knowledge transfer to accelerate the clinical translation of novel therapies across Germany and Europe within the hPSC ecosystem.

This event is organized by the BIH Center for Regenerative Therapies at Charité, Berlin Partner, HealthCapital Berlin-Brandenburg, as well as the German Stem Cell Network (GSCN) e.V.

Program
Day 1 - February, 11
12:00: Registration with Welcome Coffee
Session 1
Moderator: Ludovic Vallier (Berlin Institute of Health)
13:00: Welcome and Introduction
- Ludovic Vallier(Berlin Institute of Health – Center for Regenerative Therapies, Max Planck Institute for Molecular Genetics)
- Daniel Besser (German Stem Cell Network (GSCN) e.V.)
- Jasmin Podufall(Berlin Partner für Wirtschaft und Technologie GmbH)
13:05: Wolfram-Hubertus Zimmermann(University Medical Center Goettingen)
“Heart Repair with Biological Ventricular Assist Tissue”
13:50: Daniel Ortmann(Berlin Institute of Health – Center for Regenerative Therapies)
“Cellular programming towards advanced therapies”
14:20: Barbara Ludwig(Universitätsklinikum Carl Gustav Carus Dresden, Medizinische Fakultät Dresden, TU Dresden)
14:50: tbc
15:10: Coffee break
Session 2
16:00: Panel - What are the challenges involved in developing human pluripotent stem cell therapies in Germany?
Moderation Panel: Christopher Baum (Berlin Institute of Health)
- Wolfram-Hubertus Zimmermann (Department of Pharmacology and Toxicology University Medical Center Goettingen)
- Françoise Carlotti (Leiden University Medical Center)
- Annette Künkele-Langer(Charité - Universitätsklinikum Berlin)
Moderator: Harald Stachelscheid (Berlin Institute of Health)
17:00: Andreas Scheel(Evotec)
17:30: Eric Metzler-Bräuchle (MyoPax)
18:00: Robert Zweigerdt (Medizinische Hochschule Hannover)
18:30: Networking with Dinner and Industry exhibition*
20:00: End Day 1
Day 2 - February, 12
08:30: Registration with Welcome Coffee
Session 3
Moderator: Leila Amini (Berlin Institute of Health – Center for Regenerative Therapies)
09:00: Ludovic Vallier (Berlin Institute of Health – Center for Regenerative Therapies)
09:10: Greg Motz(Bluerock)
09:40: Boris Greber (Catalent Pharma Solutions)
10:10: Françoise Carlotti(Leiden University Medical Center)
"Toward next-generation beta-cell replacement therapy"
10:40: Fabian Bachinger(Berlin Institute of Health – Center for Regenerative Therapies)
“A hepatic patch against acute liver failure”
10:55: Coffee break
Session 4
Moderator: Daniel Besser (German Stem Cell Network (GSCN) e.V.)
11:40:Gesine Paul-Visse(Lund University)
12:25:Bo Wiinberg(Cellerator)
12:55: Olaf Strauß(Charité – Universitätsklinik Berlin)
13:25: Sebastian Knöbel(Miltenyi)
13:55: Closing Words (Ludovic Vallier, Daniel Besser, Jasmin Podufall)
14:00: End of Day 2
* The industrial exhibition takes place continuously throughout the entire duration of the event
What to expect?
- Talks & panel discussions with different stakeholders.
- Onsite networking opportunity.
- Industry exhibition to present your products and services
You should attend if you ...
- Develop or manufacture innovative therapeutic approaches
- Provide services or products that support the field of therapy development, manufacturing and translation
- Want to learn about academic vs. industrial settings for therapy development
- Expand your knowledge about clinical trials innovative products
- Explore new partnership opportunities for your institution
- Wish to expand your professional network
Who will be attending?
- Academic researchers
- manufacturers
- pharma companies
- spin-offs/start-ups
  …interested in clinical translation of innovative therapies

Key details

When:
February 11 2027 | 01:00 pm - 08:00 pm
February 12 2027 | 09:00 am - 02:00 pm

Where:
Kaiserin Friedrich Haus
Robert-Koch-Platz 7
10115 Berlin

Please note that the venue is not accessible for individuals with mobility impairments. If you have any questions about the venue or its facilities, please do not hesitate to contact Anne Schöne by email.

Registration
Due to limited capacity, early registration is recommended. Due to internal billing requirements, we kindly ask Charité and BIH staff members to register via Registration for Internal Scientists. All other participants are kindly requested to use the link Registration for External Scientists.

Registration fees

Participation fee: 50,00 €
Student participation fee: 20,00 €

Registration for Internal Scientists (Part of the Charité ecosystem, with a cost centre)

Registration for External Scientists

Industry Exhibition

Are you interested in participating in our industry exhibition at the upcoming RegMed Forum on 11 -12 February 2027? Several options are available. Find information on exhibition opportunities here. For further information, please contact Anne-Christin Schöne.